What we provide, is a system where drugs can be tested under the conditions similar to those seen by the cancer cells in the human.
What we are offering right now, are services to test drugs in our system, and we are gearing-up to provide all-inclusive kits that can be used by researchers to run these assays in their own labs.
Please let us know if you would like know things in more detail.
So far, I've only read through the abstract, but the use of Raman spectroscopy [4] for identification looks fascinating. I had no clue that it's possible to differentiate cancer cells with a spectrograph, and no, I really have no idea how or why the analysis works. On the other hand, automating test equipment in a lab is a whole lot of fun!
At the moment, the closest thing I can manage to a useful question is: Can/Will/Does your service automate this analysis method?
[1] http://biomedicaloptics.spiedigitallibrary.org/mobile/articl...
[2] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832300/
Regarding automation, the Raman spectroscopy studies was done in collaboration with a colleague at Purdue University, so at the moment, we don't have plans to extend these studies.
However, we are working on automating our workflow to streamline the set-up and analysis of our cultures. So, if you know anyone working on bio lab-related automation, we'd love an intro.
I noticed something odd in the techcrunch article; the author, Sarah Buhr (@sarahbuhr), capitalized your company name incorrectly as "IxChel" in the article title. I fixed the capitalization after submitting this to HN, and dang (Dan) or another HN admin most likely fixed the "YC-backed" to the usual "(YC S15)". You might want to ask techcrunch to fix it?
I have not (yet) read the linked papers in your site:
http://ixchelsci.com/#publications
Which I hope will provide more details, but at the moment, I'm curious how your whole system/service works?